4-nitrophenol has been researched along with Kidney Failure, Chronic in 2 studies
4-nitrophenol: RN given refers to parent cpd
mononitrophenol : A nitrophenol that is phenol carrying a single nitro substituent at unspecified position.
4-nitrophenol : A member of the class of 4-nitrophenols that is phenol in which the hydrogen that is para to the hydroxy group has been replaced by a nitro group.
Kidney Failure, Chronic: The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Paraoxonase is an esterase that hydrolyzes organophosphate compounds." | 1.30 | Decrease of serum paraoxonase activity in chronic renal failure. ( Charmes, JP; Dantoine, TF; Debord, J; Lachatre, G; Leroux-Robert, C; Marquet, P; Merle, L, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdallah, E | 1 |
| El-Shishtawy, S | 1 |
| Sherif, N | 1 |
| Ali, A | 1 |
| El-Bendary, O | 1 |
| Dantoine, TF | 1 |
| Debord, J | 1 |
| Charmes, JP | 1 |
| Merle, L | 1 |
| Marquet, P | 1 |
| Lachatre, G | 1 |
| Leroux-Robert, C | 1 |
2 other studies available for 4-nitrophenol and Kidney Failure, Chronic
| Article | Year |
|---|---|
Assessment of the relationship between serum paraoxonase activity and epicardial adipose tissue in hemodialysis patients.
Topics: Adipose Tissue; Adult; Aryldialkylphosphatase; Biomarkers; Body Mass Index; Cross-Sectional Studies; | 2017 |
Decrease of serum paraoxonase activity in chronic renal failure.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Arteriosclerosis; Aryldialkylphosphatase; Esterases; Fem | 1998 |